{"title": "Uromastyx acanthinura as a natural treatment in a mouse model of type 2 diabetes", "author": "Brito Casillas; Yeray; L\u00f3pez R\u00edos; Laura; Wiebe; Julia Charlotte; Mu\u00f1oz Mediavilla; Clara; Novoa Mogoll\u00f3n; Francisco; Ojeda; Antonio; W\u00e4gner; Anna Maria Claudia", "url": null, "hostname": null, "description": "Aims: Oral testimonies from North Africa attribute anti-diabetic effects to medicinal preparations of the lizard Uromastyx acanthinura (UA). No scientific evidence of such effects is currently available. The acute effects of oral administration of UA to C57Bl/6J mice with diet induced diabetes were tested and, if effectiveness was shown, the effect of subchronic UA administration was assessed in the same model.Methods: Mice were fed a diet containing 60% fat for at least 12 weeks. To assess acute effects, different doses of UA or saline were orally administered with 2 g of glucose/kg during an oral glucose tolerance test (OGTT) on different days in a randomised crossover design. The most effective dose was then fed together with the high-fat diet for 90 days and compared to high fat diet alone in a parallel design. Body weight (BW), food consumption, welfare, and external appearance were assessed weekly. HbA1c, OGTT, and intraperitoneal insulin tolerance tests (IPITT) were performed at baseline and after treatment. Severity of neuropathy was evaluated by cold allodynia response in the acetone test.Results: UA significantly decreased glucose levels as compared to saline 15 min after administration. After 90 days of treatment, no differences were seen in OGTT or HbA1c between the groups, while IPITT showed higher glucose levels in UA-treated animals. Although weight increase was similar in both groups, weight tended to be higher in the treated group, which had a significantly higher daily food consumption. Cold allodynia response improved in frequency and intensity in the UA group.Conclusions: Orally administered UA acutely decreased blood glucose in diabetic mice. Paradoxically, long-term administration of UA increased food consumption, weight, and insulin resistance. Improved nociceptive response suggested an effect on pain and/or neuropathy. Although additional studies are needed to elucidate the properties and potential applications of UA, our results highlight the value of ethnomedical approaches to African traditional medicine as starting point to evaluate new bioactive components", "sitename": "1575-0922", "date": "2018-11-23", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "|T\u00edtulo:||Uromastyx acanthinura as a natural treatment in a mouse model of type 2 diabetes||Otros t\u00edtulos:||Uromastyx acanthinura como tratamiento natural en un modelo murino de diabetes tipo 2||Autores/as:||\n|\n3207 Patolog\u00eda\n3209 Farmacolog\u00eda\n320904 Medicamentos naturales\nUromastyx\nAfrican traditional medicine\nCross-over design\nAnimal reduction, et al.\nObjetivos: Testimonios orales Norteafricanos atribuyen efectos hipoglucemiantes a preparados medicinales del lagarto Uromastyx acanthinura (UA), para los que no existen evidencias cient\u00edficas actualmente. El objetivo de este trabajo fue el de investigar los efectos agudos de UA administrado oralmente en ratones diab\u00e9ticos C57Bl/6J inducidos por dieta grasa, y si se demostrase su efectividad evaluar el efecto de su administraci\u00f3n subcr\u00f3nica en el mismo modelo animal. M\u00e9todos: Fue administrada una dieta a los animales con un contenido graso del 60% durante al menos 12 semanas. Para evaluar los efectos agudos diferentes dosis de UA o suero salino fueron administrados conjuntamente con 2 g/kg de glucosa durante sobrecargas orales de glucosa (SOG), en diferentes d\u00edas, siguiendo un dise\u00f1o cruzado aleatorizado. La dosis m\u00e1s efectiva en esta fase fue entonces administrada mezclada en la dieta durante 90 d\u00edas y comparada con dieta solo en un dise\u00f1o paralelo. El peso corporal y el consumo de alimento fueron evaluados semanalmente. HbA1c, SOG, y test de tolerancia intraperitoneal a la insulina (TTIPI) fueron realizados al inicio y tras el tratamiento. La gravedad de la neuropat\u00eda fue determinada mediante la evaluaci\u00f3n de la alodinia al fr\u00edo. Resultados: El UA redujo significativamente las concentraciones de glucosa de manera aguda en comparaci\u00f3n con el control a los 15 min. tras su administraci\u00f3n. Tras 90 d\u00edas de tratamiento no se observaron diferencias en las SOG o HbA1c entre grupos, mientras que para los test de tolerancia intraperitoneal a la isulina valores m\u00e1s altos de glucosa fueron determinados en los animales tratados con UA. Aunque ambos grupos aumentaron su peso, este tendi\u00f3 a ser mayor en los tratados, que a su vez consumieron significativamente m\u00e1s comida por d\u00eda. La respuesta a la alodinia al fr\u00edo mejor\u00f3 en frecuencia e intensidad en los tratados con UA. Conclusiones: El UA administrado oralmente redujo de manera aguda la glucosa en sangre en ratones con diabetes. Parad\u00f3jicamente, su administraci\u00f3n cr\u00f3nica aument\u00f3 el consumo de alimento, el peso y la resistencia a la insulina. La mejora en la respuesta nociceptiva sugiere un efecto en el dolor y/o la neuropat\u00eda. Aunque son necesarios m\u00e1s estudios para aclarar las propiedades y posibles aplicaciones de este producto, nuestros resultados subrayan el valor de los enfoques etnom\u00e9dicos hacia la medicina tradicional africana como origen para la evaluaci\u00f3n de nuevos compuestos bioactivos\n[http://hdl.handle.net/10553/47117](http://hdl.handle.net/10553/47117) [10.1016/j.endonu.2015.08.006](https://doi.org/10.1016/j.endonu.2015.08.006) [Art\u00edculos](/handle/10553/30002) [Vista completa](/handle/10553/47117?mode=full)\nCitas SCOPUSTM\n3\nactualizado el 17-sep-2023\nCitas de WEB OF SCIENCETM\n3\nCitations\nactualizado el 09-jul-2023\nVisitas86\nactualizado el 19-ago-2023\nAltmetric\nComparte\nExporta metadatos\nLos elementos en ULPGC accedaCRIS est\u00e1n protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.", "language": null, "image": null, "pagetype": null, "links": ["#content", "https://www.ulpgc.es", "/", "?locale=es", "?locale=en", "/statistics.jsp", "/acercade.jsp", "/ayuda.jsp", "https://identificate.ulpgc.es/cas/login?service=https://accedacris.ulpgc.es/cas-login", "#", "/simple-search?query=&location=publications&rpp=50", "/simple-search?query=&location=publications&rpp=50", "/simple-search?query=&location=academic&rpp=50", "/simple-search?query=&location=theses&rpp=50", "/simple-search?query=&location=patents&rpp=50", "/handle/10553/212", "/handle/10553/52718", "/handle/10553/30018", "/handle/10553/76716", "/simple-search?query=&location=researcherprofiles", "/simple-search?query=&location=orgunits", "/simple-search?query=&location=fundings", "/", "/handle/10553/30001", "/handle/10553/30002", "http://hdl.handle.net/10553/47117", "/browse?type=author&authority=rp00652&authority_lang=en_US", "/cris/rp/rp00652", "/browse?type=author&authority=rp02893&authority_lang=en_US", "/browse?type=author&value=Wiebe%2C+Julia+Charlotte&value_lang=en_US", "/browse?type=author&value=Mu%C3%B1oz+Mediavilla%2C+Clara&value_lang=en_US", "/browse?type=author&authority=rp01824&authority_lang=en_US", "/cris/rp/rp01824", "/browse?type=author&value=Ojeda%2C+Antonio&value_lang=en_US", "/browse?type=author&authority=rp00667&authority_lang=en_US", "/cris/rp/rp00667", "/cris/journals/journals89752", "http://hdl.handle.net/10553/47117", "https://doi.org/10.1016/j.endonu.2015.08.006", "/handle/10553/30002", "/handle/10553/47117?mode=full", "https://scholar.google.com/scholar?as_q=&as_epq=Uromastyx acanthinura as a natural treatment in a mouse model of type 2 diabetes&as_occt=any", "https://plu.mx/plum/a/?doi=10.1016/j.endonu.2015.08.006", "/htmlmap", "https://www.google.es/maps/place/Universidad+de+Las+Palmas+de+Gran+Canaria+-+ULPGC/@28.0990409,-15.4898954,12z/data=!4m8!1m2!2m1!1suniversidad+de+las+palmas+de+gran+canaria!3m4!1s0xc409514173e77eb:0xbda0edfa5e221aaa!8m2!3d28.0990409!4d-15.4198576?dcr=0", "mailto:accedacris@ulpgc.es", "https://twitter.com/ulpgcresearch", "https://es-es.facebook.com/ulpgcresearch", "https://www.youtube.com/channel/UC987NTd7PpHGV9n9ATGCTeA", "https://www.ulpgc.es/sobre-esta-web/aviso-legal", "https://www.ulpgc.es/sobre-esta-web/cookies", "https://ulpgc.es/sobre-esta-web/accesibilidad", "/acercade.jsp", "/statistics.jsp", "/ayuda.jsp"]}